https://scholars.lib.ntu.edu.tw/handle/123456789/459965
標題: | The suppression of peritoneal cellular immunity in women with endometriosis could be restored after gonadotropin releasing hormone agonist treatment | 作者: | MING-YIH WU KUANG-HAN CHAO SHEE-UAN CHEN HSIN-FU CHEN YU-SHIH YANG Huang S.-C HONG-NERNG HO |
公開日期: | 1996 | 卷: | 35 | 期: | 6 | 起(迄)頁: | 510-516 | 來源出版物: | American Journal of Reproductive Immunology | 摘要: | Problem: Our previous study reported that peritoneal natural killer (NK) cytotoxicity and CD3+CD25+ lymphocyte subpopulation were suppressed in women with advanced endometriosis. Whether these phenomena are general for all stages of endometriosis and whether these alterations could be restored by long-term use of gonadotropin releasing hormone agonist (GnRHa) are further tested in this study. Method: Lymphocyte subpopulations (B cells, NK cells, T cells, and T-cell activation markers such as CD69, HLA-DR, and CD25) and NK cell cytotoxicity of peripheral blood and peritoneal fluid by dual-color flow cytometry and 51Cr release assay in 30 cases of endometriosis were compared with those in 26 controls. We also compared these changes before and after 6-month treatment with GnRHa for advanced endometriosis. Results: Compared with the controls, only those women with advanced endometriosis showed lower NK cytotoxicity in peritoneal fluid mononuclear cells (PFMC). The CD3+CD69+ lymphocyte subpopulation decreased in peripheral blood mononuclear cells (PBMC) of advanced endometriosis, while the CD3+CD25+ lymphocyte subpopulation decreased in both PBMC and PFMC of mild and advanced endometriosis. After GnRHa treatment, the CD3+CD69+ lymphocyte subpopulation increased in both PBMC and PFMC and the CD3+CD25+ lymphocyte subpopulation increased in PFMC, but not in PBMC. Conclusion: Impaired local immunological function in the PF of endometriosis was confirmed by this study and the impairments could be restored after long-term GnRHa therapy. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/459965 | ISSN: | 8755-8920 | DOI: | 10.1111/j.1600-0897.1996.tb00050.x | SDG/關鍵字: | CD3 antigen; CD69 antigen; chromium 51; gonadorelin agonist; HLA DR antigen; interleukin 2 receptor; leuprorelin; article; B lymphocyte; cell mediated cytotoxicity; cellular immunity; cellular immunodeficiency; clinical article; controlled study; disease severity; endometriosis; female; flow cytometry; human; human cell; lymphocyte subpopulation; mononuclear cell; natural killer cell; peritoneal fluid; priority journal; subcutaneous drug administration; T lymphocyte activation |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。